Lexicon Pharmaceuticals’ $250 Million Private Placement of Equity Securities

Leila Ahmed
Tagged:

Vinson & Elkins advised Lexicon Pharmaceuticals, Inc. on the deal.Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) (“Lexicon”) announced it entered into a securities purchase agreement for a private investment…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Leila Ahmed

…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here